NYSE | TSX: ACB
EDMONTON, AB, Sept. 14, 2020 /CNW/ - Aurora Cannabis Inc. (the
"Company" or "Aurora") (NYSE: ACB) (TSX: ACB), the Canadian company
defining the future of cannabinoids worldwide, announced today that
it has scheduled a conference call to discuss the results for its
fourth quarter and year ended June 30,
2020 on Tuesday, September 22,
2020 at 5:00 p.m. Eastern
Time. Miguel Martin, Chief
Executive Officer, and Glen Ibbott,
Chief Financial Officer, will host the call and a question and
answer period. The Company will report its financial results for
the fourth quarter after the close of markets on Tuesday, September 22, 2020.
Conference Call
Details
|
|
DATE:
|
Tuesday, September
22, 2020
|
TIME:
|
5:00 p.m. Eastern
Time | 3:00 p.m. Mountain Time
|
WEBCAST:
|
http://public.viavid.com/index.php?id=141462
|
REPLAY:
|
(844) 512-2921 or
(412) 317-6671
Available until 11:59
p.m. Eastern Time Tuesday, October 6, 2020
|
PIN
NUMBER:
|
13710020
|
Additionally, Aurora would like to announce that along with the
filing of its annual financial statements, it expects to file other
annual disclosure documents – including the Annual Information
Form. Furthermore, Aurora announced that it has scheduled its
Annual General Meeting of shareholders, which due to the COVID-19
pandemic, will be held virtually on Tuesday,
November 12, 2020 at 10:00 am
Mountain time. In conjunction with the Meeting, Aurora
expects to file its Information Circular and related proxy
materials which will be available for download under its profile on
both SEDAR and EDGAR.
As part of its annual disclosure documents and following the
Company's first year of Sarbanes Oxley Act (SOX) section 404
implementation for the year ending June 30,
2020, the Company is currently validating but expects to
report certain material weaknesses in the Company's internal
control framework. These material weaknesses are a result of a
number of significant changes to the Company during the fiscal
year, including the Business Transformation Plan announced in
February 2020. The Company is already
in the process of remediating identified control deficiencies, and
does not expect any changes to its previously reported financial
results as a result of these material weaknesses.
About Aurora
Aurora is a global leader in the cannabis industry serving both
the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in
global cannabis dedicated to helping people improve their lives.
The Company's brand portfolio includes Aurora, Aurora Drift, San
Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler,
and Reliva. Providing customers with innovative, high-quality
cannabis and hemp products, Aurora's brands continue to break
through as industry leaders in the medical, performance, wellness
and recreational markets wherever they are launched. For more
information, please visit our website at www.auroramj.com.
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
Index.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words
such as "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain
events or conditions "may" or "will" occur. These forward-looking
statements are only predictions. Various assumptions were used in
drawing the conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions, estimates and
assumptions of management in light of management's experience and
perception of historical trends, current conditions and expected
developments at the date the statements are made, such as current
and future market conditions, the current and future regulatory
environment and future approvals and permits. Forward-looking
statements are subject to a variety of risks, uncertainties and
other factors that management believes to be relevant and
reasonable in the circumstances could cause actual events, results,
level of activity, performance, prospects, opportunities or
achievements to differ materially from those projected in the
forward-looking statements, including general business and economic
conditions, changes in laws and regulations, product demand,
changes in prices of required commodities, competition, the effects
of and responses to the COVID-19 pandemic and other risks,
uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information form dated September 10, 2019 (the "AIF") and filed
with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com. The Company cautions that
the list of risks, uncertainties and other factors described in the
AIF is not exhaustive and other factors could also adversely affect
its results. Readers are urged to consider the risks, uncertainties
and assumptions carefully in evaluating the forward-looking
statements and are cautioned not to place undue reliance on such
information. The Company is under no obligation, and expressly
disclaims any intention or obligation, to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by
applicable securities laws.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-to-host-fourth-quarter-and-full-fiscal-year-2020-investor-conference-call-and-related-year-end-informational-filings-301129853.html
SOURCE Aurora Cannabis Inc.